Just a little bit more patience….
作者信息
Montravers Philippe, de Tymowski Christian, Assadi Maksud, Yung Sonia, Kantor Elie
机构信息
Département d'Anesthésie-Réanimation, CHU Bichat-Claude Bernard, DMU PARABOL, HUPNVS, AP-HP, Paris, France; Université de Paris, Paris, France; Inserm UMR 1152, Université de Paris, Paris, France.
Département d'Anesthésie-Réanimation, CHU Bichat-Claude Bernard, DMU PARABOL, HUPNVS, AP-HP, Paris, France; Université de Paris, Paris, France; Inserm UMR 1149, Université de Paris, Paris, France.
出版信息
Anaesth Crit Care Pain Med. 2020 Jun;39(3):383-384. doi: 10.1016/j.accpm.2020.05.004. Epub 2020 May 13.
Abstract
摘要
相似文献
1
Just a little bit more patience….再耐心一点……
Anaesth Crit Care Pain Med. 2020 Jun;39(3):383-384. doi: 10.1016/j.accpm.2020.05.004. Epub 2020 May 13.
2
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
3
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
4
Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.2019年冠状病毒病（COVID-19）治疗的临床试验：对迫切需求的快速响应。
Sci China Life Sci. 2020 May;63(5):774-776. doi: 10.1007/s11427-020-1660-2. Epub 2020 Feb 29.
5
Treatment considerations for coronavirus (COVID-19).冠状病毒（COVID-19）的治疗考量
Hosp Pract (1995). 2020 Aug;48(3):119-120. doi: 10.1080/21548331.2020.1754618. Epub 2020 Apr 13.
6
Curing COVID-19.治愈新冠病毒肺炎
Lancet Infect Dis. 2020 Oct;20(10):1101. doi: 10.1016/S1473-3099(20)30706-4. Epub 2020 Sep 10.
7
Favipiravir, an antiviral for COVID-19?法匹拉韦，一种用于治疗新冠肺炎的抗病毒药物？
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
8
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染导致新型冠状病毒肺炎（COVID-19）患者出现腹泻作为首发症状。
Gut. 2020 Jun;69(6):1143-1144. doi: 10.1136/gutjnl-2020-320891. Epub 2020 Mar 5.
9
Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late.知识来得如此之快，以至于对新冠病毒肺炎治疗的荟萃分析总是为时已晚。
Pol Arch Intern Med. 2020 Sep 30;130(9):721-723. doi: 10.20452/pamw.15627.
10
Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia.沙利度胺应作为新冠肺炎肺炎的一种治疗选择进行测试。
Skinmed. 2020 Aug 1;18(4):254-255. eCollection 2020.
引用本文的文献
1
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.用于治疗新型冠状病毒肺炎的恢复期血浆疗法：当前全球大流行中的观点与应用
Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020.
本文引用的文献
1
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
2
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.美国传染病学会关于2019冠状病毒病患者治疗与管理的指南
Clin Infect Dis. 2020 Apr 27. doi: 10.1093/cid/ciaa478.
3
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
4
Adaptive designs in clinical trials: why use them, and how to run and report them.临床试验中的适应性设计：为何使用它们，以及如何实施和报告它们。
BMC Med. 2018 Feb 28;16(1):29. doi: 10.1186/s12916-018-1017-7.
Zotero 插件